All the news

Achieving the elimination of hepatitis C in people who inject drugs will require a comprehensive health system-wide strategy that addresses stigma, barriers to care, financing, the involvement of people who inject drugs and ...

Deaths from end-stage liver disease and liver cancer caused by hepatitis C in the United Kingdom fell by 11% in 2017, provisional figures from Public Health England released on 28 July show. Most ...

The reduction in new hepatitis C virus (HCV) infections that has taken place in Scotland since 2008 is most likely due to increased provision of needle and syringe programmes and ...

Georgia is making strong progress towards eliminating hepatitis C but will need triple the number of people starting treatment if it is to reach its national elimination target of a ...

A 12-week course of sofosbuvir/ledipasvir proved highly effective in a sub-Saharan African setting, results of a study carried out in Rwanda show. The findings were presented on Friday at the ...

Inviting migrants and their children by post to test for hepatitis B and C in primary care settings results in the identification of a high prevalence of previously undiagnosed infections, ...

Hepatitis C virus (HCV) infection can be rapidly eliminated in prison populations with the use of direct-acting antivirals (DAAs), results of an Australian study published in Clinical Infectious Diseases suggests. ...

Elimination of hepatitis C among people who inject drugs in Europe will require simultaneous scale-up of direct-acting antiviral treatment, needle and syringe programmes (NSP) and opioid substitution therapy (OST), and ...

NHS England announced this week that it aims to eliminate hepatitis C by 2025 – if it can negotiate 'best value for money' deals with the pharmaceutical industry in a new round ...

Eliminating hepatitis C virus (HCV) as a global public health concern is feasible, but to do this more people need to be tested and treated and prices of direct-acting antivirals ...